Congress Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Sell
1,916
-978
-34% -$203K ﹤0.01% 344
2026
Q1
$650K Sell
2,894
-843
-23% -$210K ﹤0.01% 361
2025
Q4
$900K Sell
3,737
-2,890
-44% -$739K 0.01% 318
2025
Q3
$1.81M Buy
6,627
+1,637
+33% +$447K 0.01% 289
2025
Q2
$1.29M Sell
4,990
-484,773
-99% -$116M 0.01% 307
2025
Q1
$110M Sell
489,763
-34,196
-7% -$7.98M 0.82% 39
2024
Q4
$120M Sell
523,959
-43,509
-8% -$10.5M 0.81% 45
2024
Q3
$139M Sell
567,468
-4,819
-0.8% -$1.08M 0.94% 31
2024
Q2
$110M Sell
572,287
-11,923
-2% -$2.42M 0.79% 54
2024
Q1
$116M Buy
584,210
+6,231
+1% +$1.14M 0.83% 57
2023
Q4
$99.4M Buy
577,979
+48,523
+9% +$7.46M 0.78% 59
2023
Q3
$78.3M Sell
529,456
-13,698
-3% -$2.48M 0.69% 72
2023
Q2
$119M Sell
543,154
-4,607
-0.8% -$1.03M 1.03% 28
2023
Q1
$120M Buy
547,761
+6,452
+1% +$1.4M 1.12% 28
2022
Q4
$113M Sell
541,309
-15,818
-3% -$3.48M 1.13% 21
2022
Q3
$122M Sell
557,127
-10,436
-2% -$2.38M 1.3% 12
2022
Q2
$119M Sell
567,563
-8,509
-1% -$1.81M 1.14% 20
2022
Q1
$140M Buy
576,072
+38
+0% +$9.19K 1.19% 20
2021
Q4
$150M Sell
576,034
-8,919
-2% -$2.31M 1.14% 30
2021
Q3
$154M Sell
584,953
-6,593
-1% -$1.8M 1.2% 25
2021
Q2
$146M Sell
591,546
-9,020
-2% -$1.9M 1.22% 22
2021
Q1
$117M Sell
600,566
-18,591
-3% -$3.73M 1.05% 36
2020
Q4
$132M Sell
619,157
-3,632
-0.6% -$724K 1.24% 23
2020
Q3
$107M Sell
622,789
-28,407
-4% -$5.25M 1.16% 32
2020
Q2
$125M Sell
651,196
-38,026
-6% -$6.22M 1.49% 11
2020
Q1
$102M Sell
689,222
-66,169
-9% -$10.5M 1.55% 9
2019
Q4
$117M Sell
755,391
-37,296
-5% -$5.38M 1.43% 9
2019
Q3
$107M Sell
792,687
-59,640
-7% -$7.81M 1.38% 9
2019
Q2
$104M Sell
852,327
-27,139
-3% -$3.01M 1.32% 16
2019
Q1
$91.4M Sell
879,466
-18,536
-2% -$1.91M 1.2% 28
2018
Q4
$102M Sell
898,002
-65,069
-7% -$6.97M 1.54% 3
2018
Q3
$111M Sell
963,071
-26,486
-3% -$2.9M 1.44% 7
2018
Q2
$102M Sell
989,557
-39,759
-4% -$4.02M 1.41% 9
2018
Q1
$101M Sell
1,029,316
-49,329
-5% -$4.66M 1.43% 5
2017
Q4
$91.3M Buy
1,078,645
+23,714
+2% +$1.96M 1.33% 13
2017
Q3
$81.2M Buy
1,054,931
+38,866
+4% +$2.97M 1.26% 16
2017
Q2
$79.1M Buy
1,016,065
+90,660
+10% +$6.49M 1.42% 12
2017
Q1
$66.6M Buy
925,405
+60,609
+7% +$4.19M 1.27% 18
2016
Q4
$53.7M Buy
864,796
+142,056
+20% +$8.7M 1.12% 34
2016
Q3
$46.8M Buy
722,740
+53,083
+8% +$3.53M 1.03% 45
2016
Q2
$42.3M Buy
669,657
+59,227
+10% +$3.49M 0.98% 46
2016
Q1
$35.3M Buy
+610,430
New +$34.6M 0.85% 56

Other funds holding RMD

Congress Asset Management's RMD Position: Q2 2026 in Review

Congress Asset Management reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $203K and leaving 1,916 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Congress Asset Management first reported a position in RMD in Q1 2016 and has held it in 42 quarters since. The position peaked at $154M in Q3 2021. 126 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Congress Asset Management held 1,916 shares of ResMed worth $373K as of Q2 2026.
  • Congress Asset Management sold 978 ResMed shares in Q2 2026, an estimated $203K.
  • ResMed made up ﹤0.01% of Congress Asset Management's portfolio in Q2 2026, its #344 holding.
  • Congress Asset Management first reported a position in ResMed in Q1 2016 and has held it in 42 quarters since.
  • Congress Asset Management's ResMed position peaked at $154M in Q3 2021.
  • 126 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.